To investigate whether MHY2013 has beneficial effects on skeletal muscle, we measured mRNA expression levels of fatty acid oxidation-related genes and irisin, a recently identified myokine that improves obesity-related metabolic syndrome. This evidence concerns the gene FNDC5 and obesity disorder.